BSE · KABRADG

Kabra Drugs Ltd

Sector: Healthcare · ISIN: INE323K01017

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.

Market cap rank

#3,460

of 5,084 stocks

🏆 New peak

▲ 421W

Peak #3,460 · 30 Sep 2026

A microcap name in Healthcare, Kabra Drugs Ltd trades at an undemanding earnings multiple, is growing revenue rapidly, and has a widely-held ownership base, with promoters at just 0%. Ownership as of Jun 2026.

Market Cap

49.03 Cr

P/E Ratio

9.89

P/B Ratio

1.66

ROE

16.75%

ROCE

19.34%

Dividend Yield

—

52W High

—

52W Low

—

Quarterly financials

Metric	Q1 2026-27	Q4 2025-26	Q3 2025-26	Q2 2025-26
Revenue	46.22 Cr	35.41 Cr	30.42 Cr	19.76 Cr
Net Profit	2.12 Cr	1.06 Cr	2.57 Cr	1.84 Cr
EPS	0.90	0.45	1.08	0.77
Operating Profit	2.85 Cr	1.44 Cr	2.60 Cr	2.21 Cr

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter

0.00%

Public

100.00%

PUBLIC BREAKDOWN

Individuals

93.10%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

Ex-Date	Type	Details
13 Sep 2006	Other	General

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs